SLV310
SLV310 is an orally active dopamine D2 receptor antagonist (Ki: 5 nM) and serotonin reuptake receptor inhibitor. SLV310 antagonizes Apomorphine (HY-12723) induced climbing behaviour and 5-HTP (HY-N0122) induced serotonin syndrome like behaviour in mice (ED50: 5.6 and 5.9 mg/kg, p.o.) . SLV310 is an antipsychotic compound and can be used for schizophrenia research[1].
Product Specifications
CAS Number
[264869-71-8]
UNSPSC
12352005
Target
Dopamine Receptor; Serotonin Transporter
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/slv310.html
Smiles
O=C1C2=C(C(N1CCCCN3CC=C(CC3)C4=CNC5=C4C=C(F)C=C5)=O)C=CC=C2
Molecular Formula
C25H24FN3O2
Molecular Weight
417.48
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Probable replication-associated protein repA2 (repA2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Probable replication-associated protein repA2 (repA2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Probable replication-associated protein repA2 (repA2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Probable replication-associated protein repA2 (repA2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Probable replication-associated protein repA2 (repA2)